【レポートの概要（一部）】
Table of Content
PART 01: Executive summary
• Highlights
PART 02: Scope of the report
• Market overview
• Top-vendor offerings
PART 03: Market research methodology
• Research methodology
• Economic indicators
PART 04: Introduction
• Key market highlights
PART 05: Autoimmune and inflammatory diseases
• Rheumatoid arthritis
• IBD
• Top immunomodulators for rheumatoid arthritis and IBD
PART 06: Pipeline portfolio
PART 07: Market landscape
• Market overview
• Market size and forecast
• Five forces analysis
PART 08: Market segmentation by type of disease
• Global rheumatoid arthritis immunomodulators market
• Global IBD immunomodulators market
PART 09: Market segmentation by molecule type
• Global autoimmune and inflammatory biologic immunomodulators market
• Global autoimmune and inflammatory small molecule immunomodulators market
PART 10: Geographical segmentation
• Global autoimmune and inflammatory immunomodulators market by geography 2015-2020
• Autoimmune and inflammatory immunomodulators market in Americas
• Autoimmune and inflammatory immunomodulators market in EMEA
• Autoimmune and inflammatory immunomodulators market in APAC
PART 11: Market drivers
• Strong adoption of TNF-alpha inhibitors and B-cell inhibitors
• Development of novel therapies using innovative technologies
• Improved diagnostic tools increase the treatment-seeking population
PART 12: Impact of drivers
PART 13: Market challenges
• Discontinuation of drugs under development leading to substantial loss of revenue
• Growing popularity of alternative treatment procedures hinders the market growth
• Adverse effects of the drugs
PART 14: Impact of drivers and challenges
PART 15: Market trends
• Emergence of oral agents likely to improve patient outcomes
• Advent of biosimilars expected to improve the treatment rates
• Focus on regenerative medicines
• Strategic alliances and acquisitions
PART 16: Vendor landscape
• Competitive scenario
• Other prominent vendors
PART 17: Key vendor analysis
• AbbVie
• Johnson & Johnson
• Amgen
• F. Hoffmann-La Roche
• Pfizer
PART 18: Appendix
• List of abbreviations
PART 19: Explore Technavio
[List of Exhibits]
Exhibit 01: Product offerings
Exhibit 02: Different classes of immunosuppressant drugs based on their mechanism of action
Exhibit 03: Key buying criteria for global autoimmune and inflammatory immunomodulators market 2015
Exhibit 04: Key customer segments of autoimmune and inflammatory immunomodulators market
Exhibit 05: Etiology of autoimmune diseases
Exhibit 06: Pipeline portfolio: Rheumatoid arthritis immunomodulators
Exhibit 07: Pipeline portfolio: Ulcerative colitis immunomodulators
Exhibit 08: Pipeline portfolio: Crohn’s disease immunomodulators
Exhibit 09: Global autoimmune and inflammatory immunomodulators market snapshot: Developed and emerging markets 2015
Exhibit 10: Factors influencing global autoimmune and inflammatory immunomodulators market
Exhibit 11: Approval and patent expiries of top-selling biologics
Exhibit 12: Impact of factors affecting the market 2015 and 2020
Exhibit 13: Global autoimmune and inflammatory immunomodulators market 2015-2020 ($ billions)
Exhibit 14: Five forces analysis
Exhibit 15: Segmentation of global autoimmune and inflammatory immunomodulators by type of disease based on revenue 2015
Exhibit 16: Global autoimmune and inflammatory immunomodulators market by disease type 2015-2020
Exhibit 17: Global rheumatoid arthritis immunomodulators market 2015-2020 ($ billions)
Exhibit 18: Opportunities across rheumatoid arthritis industry
Exhibit 19: Global IBD immunomodulators market 2015-2020 ($ billions)
Exhibit 20: Global IBD therapeutics market segmentation growth lifecycle analysis
Exhibit 21: Global IBD immunomodulators market by disease type 2015-2020
Exhibit 22: Global ulcerative colitis immunomodulators market 2015-2020 ($ billions)
Exhibit 23: Global Crohn’s disease immunomodulators market 2015-2020 ($ billions)
Exhibit 24: Comparative graph of global autoimmune and inflammatory immunomodulators market by molecule type ($ billions)
Exhibit 25: Global autoimmune and inflammatory biologic immunomodulators market 2015-2020 ($ billions)
Exhibit 26: Biologicals approvals by the US FDA
Exhibit 27: Global rheumatoid arthritis biologic immunomodulators market 2015-2020 ($ billions)
Exhibit 28: Global IBD biologic immunomodulators market 2015-2020 ($ billions)
Exhibit 29: Global autoimmune and inflammatory small molecule immunomodulators market 2015-2020 ($ billions)
Exhibit 30: Global autoimmune and inflammatory immunomodulators market by geography 2015-2020
Exhibit 31: Global autoimmune and inflammatory immunomodulators market segmentation by geography 2015-2020 ($ billions)
Exhibit 32: Global share of autoimmune and inflammatory immunomodulators market by geography 2015
Exhibit 33: Global autoimmune and inflammatory immunomodulators market segmentation by region: Market growth lifecycle analysis 2015
Exhibit 34: Global autoimmune and inflammatory immunomodulators market: Country analysis based on revenue and growth rate
Exhibit 35: Opportunity analysis of autoimmune and inflammatory immunomodulators market in Americas
Exhibit 36: Autoimmune and inflammatory immunomodulators market in Americas 2015-2020 ($ billions)
Exhibit 37: Opportunity analysis of autoimmune and inflammatory immunomodulators market in EMEA
Exhibit 38: Autoimmune and inflammatory immunomodulators market in EMEA 2015-2020 ($ billions)
Exhibit 39: Opportunity analysis of autoimmune and inflammatory immunomodulators market in APAC
Exhibit 40: Autoimmune and inflammatory immunomodulators market in APAC 2015-2020 ($ billions)
Exhibit 41: Sales performance of key TNF-alpha inhibitors and B-cell inhibitors ($ billions)
Exhibit 42: Key vendors: Developing novel therapies
Exhibit 43: Key developments leading to improved diagnostics
Exhibit 44: Impact of drivers
Exhibit 45: List of few immunomodulators that were discontinued from development or market
Exhibit 46: CAM therapies for rheumatoid arthritis
Exhibit 47: Usage of CAM therapies in US adults
Exhibit 48: List of CAM therapies and items used in Crohn’s disease and ulcerative colitis
Exhibit 49: List of adverse side effects associated with rheumatoid arthritis
Exhibit 50: Impact of drivers and challenges
Exhibit 51: Key marketed and pipeline oral agents
Exhibit 52: List of few biosimilars under development for various indications
Exhibit 53: List of few regenerative medicines under development for rheumatoid arthritis and IBD
Exhibit 54: Key deals in global immunomodulators market
Exhibit 55: Market share of key vendors 2015
Exhibit 56: Geographical presence of key vendors
Exhibit 57: Competitive scenario of global autoimmune and inflammatory immunomodulators market vendors 2015-2020
Exhibit 58: AbbVie: Strength assessment
Exhibit 59: AbbVie: Strategy assessment
Exhibit 60: AbbVie: Opportunity assessment
Exhibit 61: AbbVie: YoY growth and revenue of Humira 2013-2015 ($ billions)
Exhibit 62: Johnson & Johnson: Strength assessment
Exhibit 63: Johnson & Johnson: Strategy assessment
Exhibit 64: Johnson & Johnson: Opportunity assessment
Exhibit 65: Johnson & Johnson: YoY revenue and growth rate of Remicade 2013-2015 ($ billions)
Exhibit 66: Johnson & Johnson: YoY revenue and growth rate of Simponi/Simponi Aria 2013-2015 ($ billions)
Exhibit 67: Amgen: Strength assessment
Exhibit 68: Amgen: Strategy assessment
Exhibit 69: Amgen: Opportunity assessment
Exhibit 70: Amgen: YoY revenue and growth rate of Enbrel (in the US and Canada) 2013-2015 ($ billions)
Exhibit 71: F. Hoffmann-La Roche: Strength assessment
Exhibit 72: F. Hoffmann-La Roche: Strategy assessment
Exhibit 73: F. Hoffmann-La Roche: Opportunity assessment
Exhibit 74: F. Hoffmann-La Roche: YoY growth and revenue of MabThera/Rituxan for immunology segment 2013-2015 ($ billions)
Exhibit 75: F. Hoffmann-La Roche: YoY growth and revenue of Actemra/RoActemra for immunology segment 2013-2015 ($ billions)
Exhibit 76: Pfizer: Strength assessment
Exhibit 78: Pfizer: Strategy assessment
Exhibit 79: Pfizer: Opportunity assessment
Exhibit 80: Pfizer: Global autoimmune and inflammatory immunomodulators revenues 2014-2015 ($ billions)
【レポート販売概要】
■ タイトル：自己免疫および炎症性免疫調節剤の世界市場2016-2020■ 英文：Global Autoimmune and Inflammatory Immunomodulators Market 2016-2020
■ 発行日：2016年11月3日
■ 調査会社：Technavio
■ 商品コード：IRTNTR10705
■ 調査対象地域：グローバル
- ソリッドステートドライブ（SSD）の世界市場動向・予測（～2022）The solid state drives market is expected to reach USD 25.30 Billion by 2022, at a CAGR of 9.5% between 2016 and 2022. Solid state drive are gaining traction in the market due to their advantages over traditional hard disk drives (HDDs). Solid state drive have no moving parts, which reduces the risk of mechanical failures of SSDs and allows data transfer at a high speed. In addition, SSDs are more …
- ラム酒の世界市場2015-2019About Rum Rum is a distilled alcoholic beverage made through the process of fermentation and distillation. Rum is generally made from the by-products of sugarcane. The economic prosperity has pushed the sales of premium rum brands across the globe. Technavio's analysts forecast the global rum market to grow at a CAGR 2.5% in terms of revenue during 2014-2019. [Covered in this Report] The global ru …
- 熱可塑性複合材料の世界市場予測（～2024年）The thermoplastic composites market is projected to register a CAGR of 5.2%, in terms of value, between 2019 and 2024. The thermoplastic composites market size is estimated to grow from USD 28.0 billion in 2019 to USD 36.0 billion by 2024, at a CAGR of 5.2% between 2019 and 2024. Thermoplastic composites are used in a wide array of applications, such as transportation, consumer goods & electronics …
- カジノゲームの世界市場About Casino Gaming Casino is a place that hosts various types of gambling activities. Modern casino includes hotels, restaurants, shopping malls, and various other tourist attractions; it is an indoor amusement park. In casinos, the majority of the revenue comes from gambling. Gambling is illegal in many parts of the globe, making it a concentrated market. However, with the growing popularity and …
- Fatigue：グローバル臨床試験レビューH1, 2013Fatigue Global Clinical Trials Review, H1, 2013 Summary GlobalData's clinical trial report, “Fatigue Global Clinical Trials Review, H1, 2013" provides data on the Fatigue clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Fatigue. It includes an overview of the trial numbers and their recruitment status as per the site of trial conductio …
- 世界のLTE通信市場データThe bundle World LTE market includes two deliverables: 1. A database (updated half-yearly): quantitative & qualitative data for 45 countries, 6 zones & world consolidated - 76 LTE operator sheets are also available. It gathers information about spectrum issues, technologies, revenue & subscriber data & forecasts up to 2018. 2. A report (updated half-yearly) providing you with the state-of-the-art …
- 海洋掘削の世界市場2015-2019About Offshore Drilling Offshore drilling is a type of oil extraction in which wellbores are drilled through the seabed. It is typically carried out for the extraction of petroleum that lies in the rock formation beneath the seabed. Offshore drilling is categorized into shallow water drilling and deep water drilling. Offshore drilling activity that takes place in a range of 0-650 feet falls under …
- 伸縮性導電材料の世界市場予測（～2022）：グラフェン、カーボンナノチューブ、銀、銅The stretchable conductive material market was valued at USD 0.1 Million in 2015 and is expected to reach USD 6.5 Million by 2022, growing at a CAGR of 79.10% during the forecast period. The increasing use of stretchable conductors in consumer electronics and advancements in design strategies, assembly techniques, and materials and the higher operational speed through the miniaturization of electr …
- 交通部門におけるモバイルチケットの世界市場2017-2021About Mobile Ticketing Market in the Transportation Sector Mobile ticketing is an initiative to enhance the role of mobile phones in ticketing services. The use of mobile phones enables consumers to buy tickets and carry the tickets within the phone’s secure universal integrated circuit card. This works as an alternative to the traditional electronic card-based tickets and provides additional func …
- 黄熱(Yellow Fever)：世界の治験レビュー2014年下半期版Yellow Fever Global Clinical Trials Review, H2, 2014 Summary GlobalData's clinical trial report, “Yellow Fever Global Clinical Trials Review, H2, 2014" provides data on the Yellow Fever clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Yellow Fever. It includes an overview of the trial numbers and their recruitment status as per the sit …
- サウンドバーの世界市場2015-2019About Soundbar A soundbar is a slim unit with multiple built-in speakers. It comprises a special loudspeaker enclosure that generates sound from a single cabinet. Soundbar is designed to improve the sound quality without using loads of wires. Its compact structure eliminates the use of external wiring. Many manufacturers produce hybrid soundbar, in which the soundbar represents left, center, and r …
- Measles：医療検査市場2014The report presents a detailed analysis of the Measles diagnostics market in the US, Europe, (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Measles definition, epidemiology and etiology are reviewed. The report provides the 5-year test volume and sales forecasts by country for the following market segments: - Hospitals - Commerc …
- Rituxan (Systemic Lupus Erythematosus and Lupus Nephritis)：市場予測と分析（～2022）Rituxan (Systemic Lupus Erythematosus and Lupus Nephritis) - Forecast and Market Analysis to 2022 Summary Systemic lupus erythematosus (SLE) is a systemic inflammatory autoimmune disease that can affect any organ or tissue and is the prototypic autoimmune disease. While SLE can affect multiple major organ systems in the body, one of its most severe manifestations includes renal (kidney) involvemen …
- ASSPの世界市場2015-2019About ASSP An application-specific standard product (ASSP) is a semiconductor device used for a specific application by multiple units. It is a general purpose IC that implements a specific function and caters to a wide market and not just to one customer. Consumers prefer ASSPs as there is no need to design the required IC from scratch, making them cost-effective. They are used in communications, …
- 人工心臓弁の世界市場分析および予測MediPoint: Prosthetic Heart Valves - Global Analysis and Market Forecasts Summary The global prosthetic heart valves (PHV) market is a dynamic, billion-dollar market that is expected to grow through 2020. Recent advancements in the field of interventional cardiology have greatly improved clinical outcomes for patients. Prosthetic heart valves, including mechanical valves, tissue valves, and transc …
